Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

The Company will participate in Q4 FY24 earnings conference call organized by JM Financial Institutional Securities Limited on Wednesday, May 22, 2024 at 9:00 a.m. (IST) to discuss the financial results of the Company for the quarter ended March 31, 2024.
16-05-2024
Bigul

Metropolis Healthcare Ltd - 542650 - Board Meeting Intimation for Considering And Approving The Audited Standalone & Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2024.

Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2024 ,inter alia, to consider and approve Audited Standalone & Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2024
14-05-2024

Metropolis Health gets notice for alleged anomalies in diagnostics tests conducted in Delhi mohalla clinics

"The company has, on May 10, 2024, at around 3.56 pm, received a notice from the Anti-Corruption Branch, New Delhi, in respect of registration of enquiry for alleged anomalies in diagnostics test conducted in Aam Aadmi Mohalla Clinic," Metropolis said in a filing to the exchanges.
13-05-2024
Bigul

Metropolis Healthcare Ltd - 542650 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HDFC Mutual Fund
29-04-2024
Bigul

Metropolis Healthcare Ltd - 542650 - Compliance Certificate Pursuant To Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Pursuant to Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Compliance Certificate for the financial year ended March 31, 2024.
16-04-2024
Bigul

Metropolis Healthcare Ltd - 542650 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended March 31, 2024

Pursuant to Regulation 7(3) of the SEBI (Lising Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Compliance Certificate for the financial year ended March 31, 2024, duly signed by the Compliance Officer of the Company and the Authorised Representative of Link Intime India Private Limited, the Registrar and Share Transfer Agent of the Company.
16-04-2024
Bigul

Metropolis Healthcare Ltd - 542650 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
13-04-2024
Next Page
Close

Let's Open Free Demat Account